Entropy takes TRP-8803 to the US in head-to-head depression trial

Entropy Neurodynamics has signed an agreement with the University of California, San Francisco, to develop a US Phase 2 trial comparing its intravenous psilocin treatment TRP-8803 with the widely used antidepressant escitalopram in young adults with major depressive disorder. …